SCHEMBL9253933

SCHEMBL9253933

N=C(N)c1ccc(N2CCC(c3nnn(CCC(=O)O)n3)CC2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UBE2T Q9NPD8 1/20 0.47
KDM1A O60341 1/20 0.40
HRH3 Q9Y5N1 7/20 0.38
ITGB3 P05106 3/20 0.38
ITGA2B P08514 3/20 0.38
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ABL1 P00519 1/20 0.37
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
SMO Q99835 1/20 0.36
USP2 O75604 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9253885 0.89 UBE2T (0.44) UBE2THRH3LMNAALDH1A1SMN1; SMN2
SCHEMBL9253862 0.86 ITGB3 (0.53) ITGB3ITGA2BALDH1A1ALOX15
SCHEMBL9254596 0.82 ITGB3 (0.50) UBE2TKDM1AHRH3ITGB3ITGA2B
SCHEMBL9248909 0.75 UBE2T (0.47) UBE2TKDM1AHRH3ITGB3ITGA2B
SCHEMBL9257817 0.75 HPGD (0.43) ITGB3ITGA2BMAPTTSHRTP53
SCHEMBL9253831 0.74 UBE2T (0.40) UBE2TKDM1AHRH3ITGB3ITGA2B
SCHEMBL9250984 0.72 UBE2T (0.46) UBE2TKDM1AHRH3ITGB3ITGA2B
Hydrochloric Acid SCHEMBL9170047 0.71 ITGB3 (0.60) UBE2TITGB3ITGA2BLMNAKDM4E
SCHEMBL9258264 0.69 ITGB3 (0.64) ITGB3ITGA2BALOX15
SCHEMBL9178068 0.69 UBE2T (0.52) UBE2TKDM1AITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 EP disclosed